+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Animal Testing and Non-Animal Alternative Testing Global Market Opportunities and Strategies to 2035

  • ID: 5010747
  • Report
  • March 2020
  • Region: Global
  • 291 Pages
  • The Business Research Company
1 of 6

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 4DCell
  • BeonChip
  • BiomimX SRL
  • CN Biosystems
  • HemoShear
  • Hurel Corporation
  • MORE

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035 from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global animal testing and non-animal alternative testing market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:
Where is the largest and fastest growing market for the animal testing and non-animal alternative testing market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global animal testing and non-animal alternative testing market report to 2035 report from the publisher answers all these questions and many more.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – This section gives the segmentation of the animal testing and non-animal alternative testing market by geography and by type covered in this report.
  • Market Characteristics – This section introduces the market and provides information on market definitions of animal testing and non-animal alternative testing markets.
  • Market Value Chain Analysis - This section gives information on value chain analysis for the animal testing and non-animal alternative testing markets.
  • Non-Animal Alternative Testing Trends – This chapter describes the major trends shaping the global non-animal alternative testing market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Cost Analysis For Animal Testing and Alternative Technologies – This section describes the comparative cost analysis for animal testing and alternative methods to understand the cost-effectiveness and time efficiency of alternative methods. It includes the average cost of animal species and the cost of alternatives to conventional animal testing methods.
  • Animal Testing And Non-Animal Alternative Testing By Type And End Use – This section describes the overview of the types of non-animal alternative testing technologies. It also highlights the major developers and end-use industries in non-animal alternative testing technologies in the major geographies.
  • End-User Industries Adoption To Alternative Technologies – This section details information on the adoption of alternative technologies by top end-use industries in the USA, Germany, France, UK, and Japan. This section also includes the adoption of 3R principles by each of the top industries in the USA, China, and Europe.
  • Global Animal Testing Market Size – This section provides information on the global animal testing market by value and volume for the current and forecast period (2019-2035) and the drivers and restraints that support and restrain the growth of the market during this period.
  • Global Non-Animal Alternative Testing Market Size – This section provides information on the global non-animal alternative testing market size for the current and forecast period (2019-2035) and the drivers and restraints that support and restrain the growth of the market during this period.
  • Animal Testing And Non Animal Testing Market Regional And Country Analysis – This section contains the animal testing market by value and volume, and non-animal alternative testing market by value for the major geographies for the current and forecast period (2019-2035). This section also provides end-use industries segmentation in animal alternative testing in the major geographies.
  • Animal Testing Regulatory Landscape – This section describes the regulatory landscape for animal testing and its alternatives in major geographies. It includes information on regulatory agencies and policies governing animal testing. This section also includes the proposed regulations and guidelines that are driving the non-animal alternative testing technologies market in major geographies.
  • Competitive Landscape For Alternative Technologies – This section briefs information on major companies involved in the alternative technology market in the USA, China, and Europe. This section includes the profiles of the major alternative technology developers with information on their product portfolio, financial analysis, and strategies implemented by these companies.
  • Conclusions & Recommendations – Conclusions drawn from the market study are provided in this section. Further, recommendations on the promotion of alternative testing products, the place for demand, the scope for collaborations requirement, and others are also described in this section.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • By Type Of End Use Industrial Application: Pharmaceuticals; Academic Research; Medical Devices; Chemicals & Pesticides; Cosmetics; Others

Companies Mentioned: Emulate, Inc.; Organovo Holdings, Inc.; MatTek Corporation; EMD Millipore; China Tissue Engineering Co., Ltd. (J-TEC); ReproCell Inc; Organ Technologies Co, Ltd; Episkin

Countries: China, Japan, Australia, USA, UK, Germany, France.

Regions: Asia Pacific, Europe, North America, and Rest of The World

Time series: Seven years forecast and eleven-year further forecast.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 4DCell
  • BeonChip
  • BiomimX SRL
  • CN Biosystems
  • HemoShear
  • Hurel Corporation
  • MORE
1. Animal Testing And Non-Animal Alternative Testing Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1.1. Segmentation By Geography
6.1.2. Segmentation By End User Industry

7. Animal Testing And Non-Animal Alternative Testing Market Characteristics
7.1.1. Animal Testing
7.1.2. Non-Animal Alternative Testing
7.1.3. Facts About Animals In Research - Functional Resemblances Of Animals To Human Body

8. Animal Testing And Non-Animal Alternative Testing Market, Value Chain Analysis
8.1.1. Animal Breeders and Suppliers
8.1.2. Non-Animal Alternative Testing Technology Developers
8.1.3. Regulatory Authorities
8.1.4. Alternative Testing Service Providers
8.1.5. End-Use Industries

9. Non-Animal Alternative Testing Trends
9.1. Increasing Collaborations & Partnerships To Reduce Animal Testing
9.2. Raising Investments And Research Grants For Developing Alternative Technologies
9.3. Non-Animal Testing Methods In The Cosmetics Industry Are Gaining Traction

10. Cost Analysis For Animal Testing And Alternative Technologies
10.1.1. Average Cost Of Laboratory Animals
10.1.2. Average Cost Of Non-Animal Alternative Testing Methods
10.1.3. Comparative Cost Analysis For Animal Testing And Alternative Methods
10.2. Costs Involved In Animal Testing, 2018

11. Animal Testing And Non-Animal Alternative Testing Market Segments
11.1. By End Use Industrial Application
11.1.1. Important Areas of Use
11.1.2. End-User Applications
11.2. Animal Testing Market By Animal Type
11.2.1. Mice
11.2.2. Rat
11.2.3. Frogs
11.2.4. Fish
11.2.5. Birds
11.2.6. Guinea pig
11.2.7. Hamster
11.2.8. Rabbits
11.2.9. Sheep
11.2.10. Dogs
11.2.11. Cats
11.2.12. Monkeys
11.2.13. Pigs
11.2.14. Others

12. Number Of Animals Used In Research, By Country
12.1.1. USA
12.1.2. Europe
12.1.3. United Kingdom (UK)
12.1.4. Germany
12.1.5. France
12.1.6. Australia
12.1.7. Canada
12.1.8. China

13. Non-Animal Alternative Testing Technologies By Type And End Use
13.1. Introduction
13.2. Types Of Non-Animal Alternative Testing Technologies
13.2.1. Cell Or Tissue Culture (In-Vitro)
13.2.2. Organ-On-Chip (OOC)
13.2.3. Global OOC Market Size And Growth
13.2.4. Global OOC Market Drivers And Restraints
13.2.5. Market Drivers
13.2.6. Market Restraints
13.2.7. In-silico (Computer-Based Models)
13.2.8. Artificial Skin Models (Skin Substitutes)
13.2.9. Other Technologies

14. End-User Industries Adoption To Alternative Testing Technologies
14.1. Adoption of Alternative Testing Technologies By Type of Industry
14.1.1. Cosmetics Industry
14.1.2. Pharmaceutical Industry
14.1.3. Medical Device Industry
14.1.4. Others
14.2. Adoption of 3R’s In USA
14.2.1. 3R Adoption In The Cosmetics Industry
14.2.2. 3R Adoption In The Pharmaceutical Industry
14.2.3. 3R Adoption In The Medical Device Industry
14.3. Adoption of 3R’s In China
14.3.1. 3R Adoption In The Cosmetics Industry
14.3.2. 3R Adoption In The Pharmaceutical Industry
14.3.3. 3R Adoption In The Medical Device Industry
14.4. Adoption of 3R’s In Europe
14.4.1. 3R Adoption In The Cosmetics Industry
14.4.2. 3R Adoption In The Pharmaceutical Industry
14.4.3. 3R Adoption In The Medical Device Industry

15. Global Animal Testing And Non-Animal Testing Market
15.1. Global Animal Testing Market Size And Growth
15.1.1. Global Animal Testing Market Value ($ Billion)
15.1.2. Global Animal Testing Market, By Volume (Million Units)
15.1.3. Drivers Of The Animal Testing Market
15.1.4. Restraints On The Animal Testing Market
15.2. Global Non-Animal Alternative Testing Market Size And Growth
15.2.1. Global Non-Animal Alternative Testing Market Value ($ Billion)
15.2.2. Drivers Of The Non-Animal Alternative Testing Market
15.2.3. Restraints On The Non-Animal Alternative Testing Market

16. Animal Testing And Non-Animal Testing Market, Regional And Country Analysis

17. USA Animal Testing And Non-Animal Alternative Testing Market
17.1. USA Animal Testing Market
17.1.1. USA Animal Testing Market Value ($ Billion)
17.1.2. USA Animal Testing Market, By Volume (Million Units)
17.2. USA Non-Animal Alternative Testing Market
17.2.1. USA Non-Animal Alternative Testing Market Value ($ Billion)
17.3. USA Animal Testing Market By End Use Industrial Application
17.3.1. Market By Value And Volume
17.3.2. Pharmaceuticals
17.3.3. Academic Research industry was the second largest
17.3.4. Medical Devices industry was the third largest
17.3.5. Chemicals And Pesticides industry was the fourth largest
17.3.6. Cosmetics industry was the smallest
17.3.7. Other industries were the fifth largest
17.3.8. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
17.4. Regulatory Landscape In The USA
17.4.1. Regulatory Bodies & Policies
17.4.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

18. Japan Animal Testing And Non-Animal Alternative Testing Market
18.1. Japan Animal Testing Market
18.1.1. Japan Animal Testing Market Value ($ Billion)
18.1.2. Japan Animal Testing Market, By Volume (Million Units)
18.2. Japan Non-Animal Alternative Testing Market
18.2.1. Japan Non-Animal Alternative Testing Market Value ($ Billion)
18.3. Japan Animal Testing Market By End Use Industrial Application
18.3.1. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
18.4. Regulatory Landscape In Japan
18.4.1. Regulatory Bodies & Policies
18.4.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

19. China Animal Testing And Non-Animal Alternative Testing Market
19.1. China Animal Testing Market
19.1.1. China Animal Testing Market Value ($ Billion)
19.1.2. China Animal Testing Market, By Volume (Million Units)
19.2. Regulatory Landscape In China
19.2.1. Regulatory Bodies & Policies
19.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

20. Australia Animal Testing And Non-Animal Alternative Testing Market
20.1. Australia Animal Testing Market
20.1.1. Australia Animal Testing Market Value ($ Billion)
20.1.2. Australia Animal Testing Market, By Volume (Million Units)
20.2. Regulatory Landscape In Australia
20.2.1. Regulatory Bodies & Policies
20.2.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

21. Europe Animal Testing And Non-Animal Alternative Testing Market
21.1. Regulatory Landscape In Europe
21.1.1. EU Directive 2010/63
21.2. Europe Non-Animal Alternative Testing Market
21.2.1. Europe Non-Animal Alternative Testing Market Value ($ Billion)

22. France Animal Testing And Non-Animal Alternative Testing Market
22.1. France Animal Testing Market
22.1.1. France Animal Testing Market Value ($ Billion)
22.1.2. France Animal Testing Market, By Volume (Million Units)
22.2. France Animal Testing Market By End Use Industrial Application
22.2.1. Market By Value And Volume
22.2.2. Pharmaceuticals
22.2.3. Academic Research industry was the second largest
22.2.4. Chemicals & Pesticides industry was the third largest
22.2.5. Medical Devices industry was the fourth largest
22.2.6. Cosmetics industry was the smallest
22.2.7. Other industries were the fifth largest
22.3. Regulatory Landscape In France
22.3.1. Regulatory Bodies & Policies
22.3.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

23. Germany Animal Testing And Non-Animal Alternative Testing Market
23.1. Germany Animal Testing Market
23.1.1. Germany Animal Testing Market Value ($ Billion)
23.1.2. Germany Animal Testing Market, By Volume (Million Units)
23.2. Germany Animal Testing Market By End Use Industrial Application
23.2.1. Market By Value And Volume
23.2.2. Pharmaceuticals
23.2.3. Academic Research industry was the second largest
23.2.4. Medical Devices industry was the third largest
23.2.5. Chemicals And Pesticides industry was the fifth largest
23.2.6. Cosmetics industry was the smallest
23.2.7. Other industries were the fifth largest
23.3. Regulatory Landscape In Germany
23.3.1. Regulatory Bodies & Policies
23.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market

24. UK Animal Testing And Non-Animal Alternative Testing Market
24.1. UK Animal Testing Market
24.1.1. UK Animal Testing Market Value ($ Billion)
24.1.2. UK Animal Testing Market, By Volume (Million Units)
24.2. UK Animal Testing Market By End Use Industrial Application
24.2.1. Market By Value And Volume
24.2.2. Pharmaceuticals
24.2.3. Academic Research industry was the second largest
24.2.4. Medical Devices industry was the third largest
24.2.5. Chemicals & Pesticides industry was the fifth largest
24.2.6. Cosmetics industry was the smallest
24.2.7. Other industries were the fourth largest
24.3. Regulatory Landscape in United Kingdom (UK)
24.3.1. Regulatory Bodies & Policies
24.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market

25. Canada Animal Testing And Non-Animal Alternative Testing Market
25.1. Canada Animal Testing Market
25.1.1. Canada Animal Testing Market Value ($ Billion)
25.1.2. Canada Animal Testing Market, By Volume (Million Units)
25.2. Regulatory Landscape In Canada
25.2.1. Regulatory Bodies & Policies
25.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

26. Rest Of The World Animal Testing And Non-Animal Alternative Testing Market
26.1. Rest Of The World Animal Testing Market
26.1.1. Rest Of The World Animal Testing Market Value ($ Billion)
26.1.2. Rest Of The World Animal Testing Market, By Volume (Million Units)
26.2. Rest of The World Non-Animal Alternative Testing Market
26.2.1. Rest of The World Non-Animal Alternative Testing Market Value ($ Billion)
26.3. Regulatory Landscape In Rest of the World (RoW)
26.3.1. Regulatory Bodies & Policies
26.3.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

27. Competitive Landscape For Non-Animal Alternative Technologies
27.1. USA Non-Animal Alternative Testing Market Competitive Landscape
27.1.1. Emulate, Inc
27.1.2. Organovo Holdings, Inc
27.1.3. MatTek Corporation
27.1.4. EMD Millipore
27.2. China Non-Animal Alternative Testing Market Competitive Landscape
27.2.1. China Tissue Engineering Co., Ltd. (J-TEC)
27.2.2. ReproCell Inc
27.2.3. Organ Technologies Co, Ltd
27.3. Europe Non-Animal Alternative Testing Market Competitive Landscape
27.3.1. Episkin

28. Animal Testing And Non Animal Alternative Testing Global Market Opportunities And Strategies
28.1. Global Animal Testing Market In 2035 – Geographies Offering Most New Opportunities
28.2. Global Non-Animal Alternative Testing Market In 2035 – Geographies Offering Most New Opportunities
28.3. Global Animal Testing And Non-Animal Alternative Testing Market In 2035 – Segments Offering Most New Opportunities
28.4. Global Animal Testing And Non-Animal Alternative Testing Market In 2023 – Growth Strategies
28.4.1. Non-Animal Alternative Testing Market Trend Based Strategies
28.4.2. Competitor Strategies

29. Conclusions & Recommendations
29.1. Conclusions
29.2. Recommendations
29.2.1. Product
29.2.2. Price
29.2.3. Place
29.2.4. Promotion
29.2.5. People
29.2.6. Need For Validated Non-Animal Alternatives For Pharma And Other End-Use Industries
29.2.7. Increasing Number Of Players In The Non-Animal Alternative Testing Market
29.2.8. Focus On Developed Countries
29.2.9. Collaborations With Technology Developers And Animal Welfare Organizations For Promotion

30. Appendix
30.1. Glossary
30.2. Market Data Sources
30.3. Research Methodology
30.3.1. OCED Accepted In Vito Tests
30.4. Survey on Animal Models & Testing Landscape in the US
30.4.1. Current Condition By Company
30.4.2. Number Of Animals Used In Testing
30.5. Expert Interviews List
30.6. Non Animal Alternative Testing Interviews
30.7. USA Interviews
30.7.1. Interview 1
30.7.2. Interview 2
30.7.3. Interview 3
30.7.4. Interview 4
30.7.5. Interview 5
30.7.6. Interview 6
30.7.7. Interview 7
30.7.8. Interview 8
30.7.9. Interview 9
30.8. China Interviews
30.8.1. Interview 10
30.8.2. Interview 11
30.8.3. Interview 12
30.8.4. Interview 13
30.8.5. Interview 14
30.8.6. Interview 15
30.9. Animal Testing Interviews
30.9.1. Interview 16
30.9.2. Interview 17
30.9.3. Interview 18
30.9.4. Interview 19
30.9.5. Interview 20
30.9.6. Interview 21
30.9.7. Interview 22

31. Interview 23
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • 4DCell
  • BeonChip
  • BiomimX SRL
  • CN Biosystems
  • HemoShear
  • Hurel Corporation
  • MORE
This report describes and evaluates the animal testing and non-alternative testing market in major geographies.

Animal testing or experiment on animals done in the early stages of drug development and for toxicity and safety assessment of medical devices, chemicals, pesticides, cosmetics, and food compounds. Animal experiments are necessary before testing on humans mainly to evaluate toxicity, pharmacokinetics, and safety of a drug or a chemical. However, there is an increasing pressure from the animal welfare organizations on governmental agencies and companies to use non-animal alternative testing technologies. These technologies include in-vitro cell and tissue cultures, organ-on-chip, computer simulations, 3D bio printing of tissues, and synthetic skin substitutes, among others. Industries such as pharmaceuticals, medical devices, chemicals & pesticides and food are increasingly adopting these technologies to replace animal testing.

Animal Testing
The global animal testing market was valued at $10.74 billion in 2019and the market is expected to grow at a compound annual growth rate (CAGR) of 4.27% during 2019-2025 and at a CAGR of 2.46% during 2025-2035. USA and Japan are the major animal testing markets in the world.The USA’s animal testing market was valued at $4.67 billion in 2019, and is expected to grow at a CAGR of 1.49% during 2019-2025 and at a CAGR of 0.57% during 2025-2035.Japan’s animal testing market was valued at $1.03 billion in 2019. The market is forecast to grow at a CAGR of 3.51% during 2019-2025, and at a CAGR of 1.73% during 2025-2035.

The growth of the animal testing market in the USA and Japan is mainly due to the rise in R&D activities in end-use industries, and regulations to conduct animal experiments before testing on humans. However, the slow anticipated future growth rates (from 2018 to 2035) can be attributed to the requirement from federal agencies on biopharma companies to adopt 3R principles (i.e. to replace, reduce, and refine animals used in the laboratory research), protests from animal welfare organizations. In 2019, the US Environmental Protection Agency (EPA) decided to rule out mammal testing for chemicals by 2035, and increasing preference by end-use industries towards the adoption of non-animal testing technologies.

Non-Animal Testing
The global non-animal alternative testing market was valued at $1.11 billion in 2019. The market is expected to grow at a CAGR of 10.40% during 2019-2025. The USA’s non-animal alternative testing technology market was valued at $0.336 billion in 2019. The USA’s market is forecast to grow at a CAGR of 11.99% through 2025. Japan's non-animal alternative testing technology market was valued at $0.058 billion in 2019 and the market is forecast to grow at a CAGR of 6.79% through 2025.

The growth in the non-animal alternative testing market is mainly due to the adoption of the 3R principles by both regulatory agencies, and end-use companies, especially in the cosmetic industry. The adoption of alternative technologies is expected to grow after 2025 post regulatory agencies’ validation and approval.

The non-animal alternative testing market trends in the USA and Japan include raising investment for the development of alternatives to animal testing technologies, increasing adoption of in-vitro and in-silico technologies by the pharmaceutical industry, and the use of non-animal testing methods in the cosmetics industry.

The major drivers of the non-animal alternative testing technologies market include technological advances in drug development, ethical concerns on animal experimentations, high costs of animal studies, government programs for non-animal testing, and increasing social awareness against animal cruelty. Factors that could hinder the growth of the non-animal testing include regulatory mandate on animal testing for drug/medical device approval, limitations in in-vitro testing technologies, and a lack of predictive ability of in-vitro testing over in-vivo testing.

The non-animal alternative testing market is fragmented with major developers contributing to around 15-20% of the total market in 2018. Some of the major developers of alternative testing technologies in the USA include Emulate Inc, Organovo Holdings, MatTek Corporation & EMD Millipore. The major Japanese developers include J-TEC, Reprocell Inc. and Organ Technologies.

Comparative Analysis And Regulatory Landscape
Animal tests including genetic toxicity, eye irritation, skin corrosion, skin sensitivity, and others are costlier when compared to non-animal testing technologies. High costs of animal testing include the cost of the animal, and the animal testing operation costs such as maintenance of animals and cost for human resource personnel. Considering all these, the costs for animal testing methods are higher than non-animal alternative testing methods.

In the USA, there are several regulatory agencies including the US Public Health Service, USDA, IACUS, AAALAC, and EPA that are responsible for animal research and welfare. Regulatory agencies for cosmetics have not mandated animal testing in the USA. However, all other industries including pharmaceuticals, medical devices, chemicals, and pesticides require animal testing for new drugs/chemicals before regulatory approval. In Japan, several regulatory agencies including the ministry of environment, MHLW, MEXT, and MAFF are responsible for conducting animal experiments. Companies in Japan are also trying to follow 3R principles from a legal, ethical and scientific point of view.

Alternative Testing Technologies In End Use Industries
Companies in the USA and Japan are developing alternative testing technologies such as cell and tissue culture (in-vitro), organ-on-chip, and in-silico technologies. Cosmetics and bio-pharma industries use these technologies to evaluate toxicity, efficacy, pharmacokinetics, and safety of a drug or a chemical. These technologies vary by the accuracy in drug screening and selection, efficacy, cost and time of the test results. Alternative technologies are widely adopted by cosmetic companies to understand eye irritation, skin irritation and safety studies of chemicals.

The cosmetics segment occupies the major market share in the alternative testing market followed by the medical devices and pharma industries. This is mainly due to the preference of choosing non-animal technologies by cosmetic companies due to several reasons such as potential cost savings, changing attitudes of consumers, and regulatory changes.

There is a need for validated non-animal alternatives for pharma and other end-use industries; hence, the non-animal alternative testing technology developers should focus on getting OECD approval for their developed technologies. The adoption rate of non-animal alternative testing technologies will be high in developed countries compared to emerging nations; hence, non-animal alternative testing technology developers should focus initially on developed markets. These developers should collaborate with animal welfare organizations for better promotion of their products.
Note: Product cover images may vary from those shown
5 of 6
  • Biochip
  • 4DCell
  • Ascendance Bio
  • BeonChip
  • BiomimX SRL
  • Cherry Biotech
  • CN Biosystems
  • Elveflow
  • HemoShear
  • Hurel Corporation
  • Hurel Corporation
  • InSphero AG,
  • Mesobiotech
  • Micronit
  • Nortis Inc.
  • Organovo Holdings, Inc.
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll